More programs, more candles, more light.

Get the Flash Player to see this player.

Loading the player ...

Panel 4: Steven Schwartz, UCLA Diabetic Eye Disease and Retinal Vascular Center

Stem Cells in Clinical Trials

November 30, 2011
20 minutes
Steven Schwartz


Dr. Schwartz’ primary areas of research include early diagnosis and treatment of diseases such as retinopathy of prematurity (ROP), diabetic eye disease, and macular degeneration. Additionally, his focus includes development and evaluation of novel medical device technologies, imaging technologies, surgical equipment (including surgical robots) and drug delivery systems, with particular emphasis on diagnostic and treatment applications. Dr. Schwartz’ clinical research focuses on trials of novel pharmacotherapeutic agents to discover treatments for both wet and dry age-related macular degeneration, ROP and diabetic retinopathy. This year, Dr. Schwartz led two new clinical trials testing the use of stem cell-derived retinal pigment epithelial cells to address vision loss in people suffering from Stargardt’s macular dystrophy and dry age-related macular degeneration.